Introduction and application of CAS No.937272-79-2 | Pacritinib
Synonyms:
14,19-Dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene,11-[2-(1-pyrrolidinyl)ethoxy]-,(16E)-;
16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaenePacritinib(SB1518);
Pacritinib,>=98%;PACRITINIB;SB1518;Pacritinib(SB1518);(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene;SB1518(Pacritinib)
Specification of CAS No.937272-79-2 | Pacritinib
|
ITEMS |
SPECIFICATION |
|
CAS |
937272-79-2 |
|
MF |
C28H32N4O3 |
|
MW |
472.58 |
|
Boiling point |
694.3±65.0 °C(Predicted) |
|
Density |
1.22±0.1 g/cm3(Predicted) |
|
acidity coefficient(pKa) |
9.56±0.20(Predicted) |
Package and transportation of Introduction and application of CAS No.937272-79-2 | Pacritinib
Package:0.1g,1g,5g,25g,100g,500g,1kg
Transportation: by courier/ by air/ by sea
Related Articles of CAS No.937272-79-2 | Pacritinib
The next generation of JAK inhibitors: an update on fedratinib, momelotonib, and pacritinib
AA Patel, O Odenike - Current Hematologic Malignancy Reports, 2020 - Springer
… Pacritinib has been studied in myelofibrosis patients with significant baseline anemia and
thrombocytopenia; these trials support the use of pacritinib in myelofibrosis patients with …
Hot Tags: cas no.937272-79-2 | pacritinib, China cas no.937272-79-2 | pacritinib manufacturers, factory, Life Science Chemicals, Proteinase K, Epsilon-polylysine, Spermidine, 1 8 DIAMINO 4 AZAOCTANE, Biochemicals
